13F HOLDINGS REPORT
BIOIMPACT CAPITAL LLC
Quarter ended Q3 2024 · Filed November 13, 2024 · Accession 0000950123-24-011026
Total Value
$666.6M
Positions
43
Other Managers
0
Confidential Omitted
No
Holdings (43)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Cullinan Therapeutics, Inc. | CGEM | 7,648,268 | $128.0M | 19.21% |
| 2 | Insmed Incorporated | INSM | 615,391 | $44.9M | 6.74% |
| 3 | Olema Pharmaceuticals, Inc. | OLMA | 2,680,596 | $32.0M | 4.80% |
| 4 | Avidity Biosciences Inc | 05370A108 | 688,975 | $31.6M | 4.75% |
| 5 | Crinetics Pharmaceuticals Inc. | CRNX | 525,845 | $26.9M | 4.03% |
| 6 | Edgewise Therapeutics Inc | EWTX | 917,166 | $24.5M | 3.67% |
| 7 | Iovance Biotherapeutics Inc | IOVA | 2,406,714 | $22.6M | 3.39% |
| 8 | Natera Inc | NTRA | 177,099 | $22.5M | 3.37% |
| 9 | Rocket Pharmaceuticals, Inc. | RCKTW | 1,066,373 | $19.7M | 2.95% |
| 10 | Mirum Pharmaceuticals Inc | MIRM | 492,723 | $19.2M | 2.88% |
| 11 | Ultragenyx Pharmaceutical Inc | RARE | 329,733 | $18.3M | 2.75% |
| 12 | iTeos Therapeutics, Inc. | 46565G104 | 1,745,943 | $17.8M | 2.67% |
| 13 | Moonlake Immunotherapeutics | MLTX | 349,063 | $17.6M | 2.64% |
| 14 | Lantheus Holdings Inc | LNTH | 150,182 | $16.5M | 2.47% |
| 15 | Madrigal Pharmaceuticals Inc | MDGL | 72,395 | $15.4M | 2.30% |
| 16 | Disc Medicine Inc | IRON | 311,761 | $15.3M | 2.30% |
| 17 | Relay Therapeutics Inc. | RLAY | 2,033,041 | $14.4M | 2.16% |
| 18 | Twist Bioscience Corp | TWST | 294,930 | $13.3M | 2.00% |
| 19 | Revolution Medicines, Inc. | RVMDW | 291,391 | $13.2M | 1.98% |
| 20 | Guardant Health Inc | GH | 499,170 | $11.5M | 1.72% |
| 21 | Akero Therapeutics Inc | 00973Y108 | 392,544 | $11.3M | 1.69% |
| 22 | Kalvista Pharmaceuticals Inc | KALV | 896,915 | $10.4M | 1.56% |
| 23 | Compass Therapeutics, Inc. | CMPX | 5,641,894 | $10.4M | 1.56% |
| 24 | Cartesian Therapeutics Inc | RNAC | 629,423 | $10.1M | 1.52% |
| 25 | Sutro Biopharma, Inc. | STRO | 2,832,064 | $9.8M | 1.47% |
| 26 | Aquestive Therapeutics Inc | AQST | 1,796,750 | $8.9M | 1.34% |
| 27 | Janux Therapeutics Inc | JANX | 171,105 | $7.8M | 1.17% |
| 28 | VIKING THERAPEUTICS INC | VKTX | 120,982 | $7.7M | 1.15% |
| 29 | Xenon Pharmaceuticals Inc | XENE | 165,800 | $6.5M | 0.98% |
| 30 | Stoke Therapeutics Inc | STOK | 479,452 | $5.9M | 0.88% |
| 31 | Repare Therapeutics, Inc. | 760273102 | 1,639,849 | $5.6M | 0.85% |
| 32 | Intellia Therapeutics, Inc. | NTLA | 267,557 | $5.5M | 0.82% |
| 33 | Zentalis Pharmaceuticals, Inc. | ZNTL | 1,465,801 | $5.4M | 0.81% |
| 34 | Trevi Therapeutics Inc | TRVI | 1,538,517 | $5.1M | 0.77% |
| 35 | Wave Life Sciences PTE LTD | WVE | 624,471 | $5.1M | 0.77% |
| 36 | Arcturus Therapeutics Holdings | ARCT | 219,508 | $5.1M | 0.76% |
| 37 | Werewolf Therapeutics, Inc. | HOWL | 2,388,011 | $5.1M | 0.76% |
| 38 | Adaptimmune Therapeutics plc | ADTI | 5,095,912 | $4.8M | 0.73% |
| 39 | ALX Oncology Holdings Inc. | ALXO | 2,409,862 | $4.4M | 0.66% |
| 40 | PTC Therapeutics Inc | PTCT | 89,715 | $3.3M | 0.50% |
| 41 | 89Bio Inc | 282559103 | 330,000 | $2.4M | 0.37% |
| 42 | REGENXBIO Inc. | RGNX | 50,000 | $524,500 | 0.08% |
| 43 | Solid Biosciences Inc | SLDB | 11,518 | $80,280 | 0.01% |